Tower Research Capital (TRC)’s Aimei Health Technology AFJK Stock Holding History
Bought
Maintained
Sold
Other funds holding AFJK
Tower Research Capital (TRC)'s AFJK Position: Q1 2025 in Review
Tower Research Capital (TRC) sold out of Aimei Health Technology (AFJK) in Q1 2025, closing a stake of 48 shares — an estimated $514 sold.
Tower Research Capital (TRC) first reported a position in AFJK in Q3 2024 and held it in 2 quarters. The position peaked at $514 in Q4 2024. 16 funds tracked by Wall St. Rank hold AFJK as of Q1 2025.
- Tower Research Capital (TRC) reported no remaining Aimei Health Technology position as of Q1 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 48 Aimei Health Technology shares in Q1 2025, an estimated $514.
- Tower Research Capital (TRC) first reported a position in Aimei Health Technology in Q3 2024 and held it in 2 quarters.
- Tower Research Capital (TRC)'s Aimei Health Technology position peaked at $514 in Q4 2024.
- 16 funds tracked by Wall St. Rank held Aimei Health Technology as of Q1 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.